Baker Mark Robert - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	25	2	3	4	5	24	20	10
P	%wins				76	80	48	48	60	56	61
S	%ret	1	1	3	2	13	19	37	18	-7	14
S	%wins				67	33	33	33	67	33	44

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/28/13 09:24	3/27/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	5.32	3	1	0	161	D	-12	-43	61	80	94	57	20	6	0	-7	-11	-18	-4	-26
2/28/13 17:24	2/27/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.72	0	1	1	160	D	-52	-73	-36	19	-19	-8	-6	-2	6	18	102	52	113	84
1/23/13 09:59	1/22/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.82	1	1	1	159	D	-53	-70	-73	-13	20	-5	-15	-8	4	5	-4	70	113	142
12/26/12 13:05	12/26/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	3.01	1	1	1	158	D	-39	-66	-66	-10	97	35	37	4	-3	9	-3	80	47	83
11/30/12 12:07	11/28/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.13	1	2	1	157	D	-54	-59	-75	-46	-26	14	10	0	4	3	32	26	81	127
11/20/12 13:41	11/19/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	23	1.96	1	12	8	155	D	-54	-67	-73	-51	-24	-30	3	29	10	6	40	33	91	90
11/19/12 13:50	11/16/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	91	1.82	1	50	53	143	D	-59	-70	-76	-58	-33	-36	-31	11	10	22	30	50	116	102
11/16/12 13:54	11/15/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	82	1.69	0	49	109	94	D	-63	-72	-80	-60	-36	-41	-42	12	9	37	38	71	145	126
10/25/12 11:34	10/24/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.96	1	1	3	45	D	-40	-55	-73	-73	-22	4	-4	-11	0	-5	-25	2	59	41
9/27/12 15:14	9/26/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	3.32	1	1	2	44	D	-40	-53	-70	-67	-28	-14	-16	-9	-1	-12	-4	-9	78	66
8/23/12 09:44	8/22/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	4.23	3	1	2	43	D	5	-32	-58	-47	-58	-9	-1	0	0	1	-20	-45	-35	24
7/26/12 11:42	7/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	10.04	2	0	1	42	D	125	63	7	-5	28	-1	0	0	5	-53	-59	-71	-71	-40
6/29/12 09:15	6/27/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.27	2	0	1	41	D	67	27	6	-8	16	8	7	1	7	13	-41	-67	-67	-51
5/24/12 12:38	5/23/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.81	1	0	1	41	D	80	12	37	-21	-19	-23	-10	5	2	9	11	-47	-71	-46
4/27/12 09:23	4/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	4	10.07	1	0	1	41	D	68	48	69	16	15	11	12	2	3	-5	-22	-2	-73	-57
3/29/12 15:12	3/28/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	10.13	1	0	1	40	D	89	57	55	14	4	10	0	5	0	0	12	-8	-70	-46
2/23/12 09:28	2/22/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.41	1	0	1	40	D	104	67	54	56	6	-4	0	-2	5	2	-1	-17	-56	-73
1/26/12 10:05	1/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.53	1	0	1	40	D	107	57	53	45	28	13	11	2	-2	4	6	12	7	-69
1/12/12 13:16	10/26/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P.m	7	7.51	3	1	2	39	D	102	58	16	43	60	5	4	4	0	6	7	10	14	-61
11/28/11 14:18	11/23/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	S	-3	5.45	1	-1	-2	38	D	24	0	-36	-15	-22	-19	-18	-13	9	39	73	94	79	-58
10/4/11 17:20	10/3/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	M.d	24	4.62	1	5	16	38	D	11	10	-11	-25	-12	-5	-5	-7	-1	-1	-1	41	69	-65
9/28/11 16:55	9/28/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.39	1	1	1	37	D	15	27	1	-15	8	12	12	12	-1	7	13	45	64	-44
8/25/11 09:31	8/24/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.08	1	1	2	36	D	13	50	9	-17	-18	17	-3	-5	-3	1	-4	-11	63	-32
7/28/11 17:06	7/27/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.12	1	1	2	36	D	9	29	-10	-23	-17	-27	-20	-14	-4	4	5	12	65	88
7/6/11 18:49	7/1/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	M.d	109	5.46	1	20	131	35	D	40	41	27	18	-3	1	5	0	3	4	-21	-28	15	42
6/24/11 10:07	6/22/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.08	1	0	2	32	D	48	29	40	13	-20	-11	-4	-2	0	4	-7	-17	28	27
5/26/11 15:15	5/25/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.13	1	0	2	31	D	43	52	56	32	3	0	-9	-2	6	6	-7	-17	-26	9
4/27/11 16:05	4/27/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.24	1	0	2	31	D	28	16	49	21	28	18	-2	-1	1	5	2	-15	-11	46
4/5/11 09:51	4/1/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	M.d	20	5.05	1	4	15	30	D	-10	13	24	8	7	7	0	-3	1	9	23	18	-11	64
1/5/11 16:29	1/3/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	M.d	21	4.83	1	4	17	30	D	-47	30	5	11	19	18	7	5	-3	-2	-1	8	30	46
10/4/10 17:39	10/1/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	M.d	76	4.32	1	18	151	29	D	-64	1	-9	-7	20	13	-1	0	4	1	-2	10	27	16
7/6/10 14:25	7/1/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	M.d	20	4.44	1	5	20	27	D	-64	7	23	-2	24	-14	2	4	-6	-2	-11	-7	0	35
6/24/10 10:20	6/22/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	S	-13	5.66	1	-2	-8	27	D	-68	9	23	1	-13	-4	-16	-12	0	3	-19	-4	-10	30
4/5/10 16:50	4/1/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	M.d	20	4.56	1	4	17	29	D	-28	-19	2	19	12	1	0	1	-3	-4	21	-4	-10	11
3/18/10 15:53	3/18/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	P	S	-12	5.33	1	-2	-7	28	D	3	-4	1	32	22	19	15	1	-2	-2	4	20	-16	7
1/6/10 15:10	1/4/10	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	18	3.78	0	5	18	31	D	-73	-59	-15	-10	7	7	-2	-3	-2	1	3	22	24	30
10/5/09 16:04	10/1/09	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	17	4.26	1	4	15	30	D	-78	-63	-28	-5	-11	-7	-9	-10	6	3	-19	-9	11	1
7/6/09 14:53	7/1/09	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	70	5.33	1	13	82	29	D	-77	-66	-50	-25	-1	1	5	0	1	2	14	-2	-13	7
4/3/09 16:32	4/1/09	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	18	5.65	1	3	13	28	D	-73	-8	-51	-34	-9	19	10	0	-7	-6	-23	-25	-26	-18
1/6/09 15:34	1/2/09	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	19	9.13	2	2	8	27										-6	-9	-29	-41	-52	-59
10/3/08 12:04	10/1/08	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	16	6.53	6	2	10	27	D	-42	-39	77	-9	10	-5	-2	-1	-5	-17	-26	-20	-49	-63
7/3/08 13:18	7/1/08	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	66	13.64	7	5	23	26	D	-37	-31	-16	104	15	-11	-9	-8	-2	10	11	-8	-32	-66
4/3/08 15:36	4/1/08	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	17	6.52	9	3	11	25	D	-72	-69	-67	-59	-52	51	23	20	0	2	84	116	79	-11
1/4/08 15:36	1/2/08	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	14	15.33	7	1	4	25	D	-30	-34	-19	-21	-13	-17	-7	-2	-7	4	-3	-56	-15	-39
10/3/07 16:51	10/1/07	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	14	19.03	8	1	3	25	D	-6	-6	-11	1	-7	-8	-3	-5	1	4	5	-18	-66	-37
7/5/07 16:54	7/2/07	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	65	18.71	8	3	16	25	D	5	-9	-15	-12	-2	1	-2	-1	2	-3	-2	2	-16	-29
4/4/07 15:22	4/2/07	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	13	20.13	8	1	6	11	D	55	-6	6	-3	-16	10	4	5	-2	3	-3	-12	-11	-70
1/5/07 14:38	1/3/07	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	12	21.88	4	1	5	11	D	61	5	12	18	-7	0	4	4	0	4	10	-8	-19	-40
10/4/06 10:49	10/2/06	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	12	19.58	4	1	6	11	D	58	-7	-13	-5	6	-6	1	-1	4	4	10	18	8	-4
7/6/06 17:20	7/3/06	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	76	25.01	5	3	40	11	D	50	10	-6	-8	17	10	8	3	-1	-6	-9	-6	11	-10
4/5/06 16:31	4/3/06	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	11	21.77	5	1	26	2										-5	-7	-10	-8	-13	-6
1/5/06 17:12	1/3/06	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	O	GC	M.d	11	20.86	7	1	30	2										9	11	3	-2	-9	1

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y